共 31 条
- [1] Vervoort D, Jin H, Edwin F, Kumar RK, Malik M, Tapaua N, Et al., Global access to comprehensive care for paediatric and congenital heart disease, CJC Pediatr Congenit Heart Dis, 2, pp. 453-463, (2023)
- [2] Shah SN, Sharma S., Mitral Stenosis, StatPearls [Internet], (2024)
- [3] Ou Z, Yu D, Liang Y, Wu J, He H, Li Y, Et al., Global burden of rheumatic heart disease: trends from 1990 to 2019, Arthritis Research & Therapy, 24, 1, (2022)
- [4] Ralph AP, Noonan S, Wade V, Currie BJ., The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease, Med J Aust, 214, 5, pp. 220-227, (2021)
- [5] Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Et al., Secondary antibiotic prophylaxis for latent rheumatic heart disease, N Engl J Med, 386, 3, pp. 230-240, (2022)
- [6] Rothenbuhler M, O'Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, Et al., Active surveillance for rheumatic heart disease in endemic regions: A systematic review and meta-analysis of prevalence among children and adolescents, Lancet Glob Health, 2, 12, pp. e717-e726, (2014)
- [7] Muhamed B, Parks T, Sliwa K., Genetics of rheumatic fever and rheumatic heart disease, Nat Rev Cardiol, 17, 3, pp. 145-154, (2020)
- [8] Tormin JPAS, Nascimento BR, Sable CA, da Silva JLP, Brandao-de-Resende C, Rocha LPC, Et al., Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease, Cytokine, 138, (2021)
- [9] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Et al., The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ, 372, (2021)
- [10] Welch VA HJ., Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)